NEW YORK, June 6 - Orchid Biosciences said Wednesday it planned to sell $33.3 million worth of common stock to a number of private investors as part of an effort to shore up its cash reserves and launch new products.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.
The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.
The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.
Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."